Its latest quarterly revenue reached 17.78M, representing a year-over-year increase of 10.63%, while its net profit experienced a year-over-year increase of 19.33%.
The current valuation score of Rockwell Medical Inc is 9.21. Its current P/E ratio is -57.80, which is -99.06% below the recent high of -0.54 and -2403.56% above the recent low of -1447.06.
The current earnings forecast score of Rockwell Medical Inc is 8.00. The average price target is 20.00, with a high of 20.00 and a low of 20.00.
The current price momentum score of Rockwell Medical Inc is 4.42. Currently, the stock price is trading between the resistance level at 9.22 and the support level at 7.60, making it suitable for range-bound swing trading.
The latest institutional shareholding proportion is 13.04%, representing a quarter-over-quarter increase of 51.97%. The largest institutional shareholder is James Simons, holding a total of 359.67K shares, representing 0.00% of shares outstanding, with 64.77% decrease in holdings.
The current risk assessment score of Rockwell Medical Inc is 1.45. The company's beta value is 1.60. This indicates that the stock tends to outperform the index during upward trending markets but experiences larger declines during downward trending markets.